In brief
The town grapples with educational shortcomings, low incomes, and a transient workforce, raising questions about its sustainability and attractiveness for residents.
Despite a monumental investment of over $8.5 billion by Novo Nordisk in Kalundborg, a town of just 16,000 on Denmark's coast, the anticipated boom has yet to fully materialize. Known as the production hub for the weight-loss drug Wegovy and diabetes medication Ozempic, Kalundborg has become a focal point for a modern economic trend. However, persuading new residents to settle in this otherwise sleepy town proves to be a challenge.The daily routine is echoed in the town's "Novo Queue," where an influx of factory workers each morning is met with an exodus in the afternoon, as most do not stay in Kalundborg. This transient nature of the workforce raises concerns, especially when considering the substantial £400,000 investment per resident in a place seemingly lacking desirable amenities.Kalundborg grapples with significant issues, including outdated schools performing below national standards, along with high rates of childhood obesity. Local educators encounter difficulties attracting experienced teachers, which breeds complacency among some parents who believe future jobs at Novo Nordisk do not require higher education. Students, like Ali and Anna K, express mixed feelings about their futures in Kalundborg, with some yearning for the excitement of larger cities.Despite this, local businesses like supermarkets and cafes are booming, benefiting from the daily influx of workers. However, stores reliant on permanent residents often struggle, leading to rapid turnover and closures. The town's demographics paint a picture where many families, priced out of the soaring capital, find themselves living on low incomes and dependent on factory jobs.Novo Nordisk's success, highlighted by sales exceeding $33 billion in the past year, stimulates the local economy, yet analysts caution against excessive reliance on such a singular industry. The town's leadership remains optimistic, with Mayor Martin Damm claiming that job creation outpaces the setbacks, and developments like a new highway aim to alleviate traffic woes.Among the youth, sentiments vary. Students like Miguel, who studies bio-technology, believe in a bright future for Kalundborg, hoping for a more multicultural environment. However, as Anna K points out, the town stands at a crucial intersection—its future trajectory uncertain.As Novo Nordisk continues its investments, time will tell if Kalundborg can transform into a thriving community rather than just a transient workspace.
